LANCASTER, PA — Trout Capital Advisors, LLC has announced it acted as the exclusive financial advisor to Universal Plastics & Engineering Company, Inc. (UNIPEC) in the company’s acquisition by UFP Technologies, Inc. (Nasdaq: UFPT), a prominent manufacturer of custom-engineered components for the medical sector.
Based in Rockville, Maryland, UNIPEC specializes in the development and production of thermoformed and heat-sealed polymer components used in Class III implantable medical devices—particularly for shielding batteries. These highly regulated applications require precision, reliability, and advanced material science, all of which position UNIPEC as a strategic addition to UFP Technologies’ growing healthcare portfolio.
“This deal represents a strong strategic outcome for the company,” said Andrew Rice, Managing Partner at Trout Capital Advisors. “We’re proud to have helped facilitate UNIPEC’s next chapter as part of UFP Technologies.”
UNIPEC President Brandt Berghers emphasized the importance of legacy in the transaction, noting that the business has been in his family since 1957. “The team at Trout Capital Advisors understood the importance of legacy, respect for our customers, and future opportunities for my employees. This outcome is beyond anything I could have imagined, and I am delighted to see UNIPEC join the UFP family.”
The acquisition underscores UFP Technologies’ continued commitment to deepening its capabilities in the medical device market, a sector where stringent regulatory demands and technical complexity create high barriers to entry—and opportunity for differentiation.
Legal counsel for UNIPEC was provided by Stephen Gierasch of McNees Wallace & Nurick. The transaction further reinforces Trout Capital Advisors’ track record in advising privately held companies within advanced manufacturing and engineered product industries.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.